Phototherapy is the use of light to treat psoriasis, eczema, vitiligo, and other photoresponsive skin disorders. During treatments, the skin is exposed to a special type of light emitted by a medical device commonly referred to as a phototherapy unit. These units range from hand-held and table-top devices for spot treatment of small areas to cabinet or “walk-in” units for patients requiring full-body treatment.
Phototherapy requires a prescription from a medical professional and can be administered in one’s home or a patient can be given treatments in their physician’s clinic. When comparing phototherapy to other treatment modalities, it is clear why phototherapy is often the first choice when treating photoresponsive skin conditions. To get started, follow the steps outlined below:
Narrow Band UVB phototherapy is considered a first-line treatment for many conditions such as psoriasis, vitiligo and eczema, is safe enough for pregnant women and children to use, and has none of the serious side effects associated with competing biological drug therapies.
Phototherapy leads other treatments in both effectiveness and speed of clearance. Narrowband UVB and PUVA (Psoralen + UVA) are safe, work extremely well, and are twice as fast at clearing patients with moderate to severe psoriasis.
Daavlin devices lead the industry in control options, integrated technology, and advanced safety features. Our ClearLink Controller is an industry first and provides an experience like no other. With its intuitive design, easy-to-navigate touch-screen control system, and personalized user safety features, Daavlin’s ClearLink Controller ensures treatment accuracy and safety.
Whether you’re in a need of a full-body treatment, or a small, handheld unit for spot or scalp treatments, Daavlin has you covered. Our product lineup contains devices that meet the needs of a wide variety of scenarios and our build quality is second to none.
1 Palmer, et al. Photoadaptation during Narrowband Ultraviolet-B Therapy Is Independent of Skin Type: A Study of 352 Patients Journal of Investigative Dermatology (2006) 126, 1256–1263
2 Yones, et al. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy. Arch Dermatol. 2006 Jul;142(7):836-42.
3 ENBREL® Physician Package Insert. Available at: http://www.enbrel.com/pdf/enbrel_pi.pdf
4 HUMIRA® Prescribing Information. Available at: http://www.rxabbott.com/pdf/humira.pdf
5 REMICADE® Prescribing Information. Available at: http://www.remicade.com/remicade/assets/HCP_PPI.pdf
6 Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris, Walters, et al. Journal of the American Academy of Dermatology, Volume 40, Issue 6, June 1999, Pages 893-900